Neurocrine Biosciences | Devedores Comerciais



Trade Debtors Alterar Data
AbbVie USD 12.48B 1.56B 2025-03
Acadia Pharmaceuticals USD 113.71M 9.02M 2025-03
Agios Pharmaceuticals USD 3.34M 765K 2025-03
ALKERMES USD 356.33M 34.58M 2025-06
Alnylam Pharmaceuticals USD 418.04M 12.73M 2025-03
Amgen USD 8.13B 1.35B 2025-03
Biogen USD 2B 127.7M 2025-03
BioMarin Pharmaceutical USD 739.18M 78.64M 2025-03
Cytokinetics USD 2.01M 14.64M 2025-03
Dynavax Technologies USD 56.56M 9.65M 2025-03
Exelixis USD 292.35M 10.72M 2025-07
Gilead Sciences USD 4.39B 32M 2025-03
Halozyme Therapeutics USD 304.62M 3.83M 2025-03
Incyte USD 842.89M 19.76M 2025-06
Ionis Pharmaceuticals USD 39.71M 52.48M 2025-03
Neurocrine Biosciences USD 516M 36.9M 2025-03
Pfizer USD 14.74B 32M 2025-03
Prothena USD 0 0 2024-12
Regeneron Pharmaceuticals USD 5.56B 650.9M 2025-03
Repligen USD 147.41M 13.3M 2025-03
Sarepta Therapeutics USD 724.52M 74.8M 2025-03
Teva Pharmaceutical Industries USD 3.38B 325M 2025-03
Ultragenyx Pharmaceutical USD 123.6M 28.5M 2024-12
Vertex Pharmaceuticals USD 1.61B 141.2M 2024-12


Neurocrine Biosciences Devedores Comerciais - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.